Extraoral Photobiomodulation for Prevention of Oral and Oropharyngeal Mucositis in Head and Neck Cancer Patients: Interim Analysis of a Randomized, Double-blind, Clinical Trial

Purpose: To assess the safety and efficacy of prophylactic extraoral photobiomodulation (PBM) for the prevention of oral and oropharyngeal mucositis (OM) on clinical outcomes and survival in patients with oral cavity and oropharyngeal squamous cell carcinoma (OOPSCC).

Methods: OOPSCC patients who received radiotherapy (RT) were prospectively randomized to two groups: prophylactic extraoral PBM and placebo. OM grade (NCI), pain (VAS), analgesia, and anti-inflammatory prescriptions were assessed weekly. Quality of life questionnaires (QoL) were performed at the first and last day of RT. Following RT, participants were evaluated quarterly for oncological outcomes follow-up.

Results: Fifty-five patients met the inclusion criteria. The first occurrence of OM was observed at week 1, for the placebo group (p = 0.014). Later, OM onset and severity was observed for the PBM group, with first occurrence at week 2 (p = 0.009). No difference in severe OM incidence was observed (p > 0.05). Lower mean pain score was noted at week 7 for the PBM group (2.1) compared to placebo group (4.5) (p = 0.009). Less analgesics (week 3; p = 0.009/week 7; p = 0.02) and anti-inflammatory prescription (week 5; p = 0.0346) were observed for the PBM group. Better QoL scores were observed for the PBM group at last day of RT (p = 0.0034). No difference in overall survival among groups was observed in 1 year of follow-up (p = 0.889).

Conclusion: Prophylactic extraoral PBM can delay OM onset, reduce pain, and reduce analgesic and anti-inflammatory prescription requirements. Extraoral PBM was associated with better QoL. There was no evidence of PBM impact on oncological outcomes.

Trial Registration: TRN:RBR-4w4swx (date of registration: 01/20/2020).

Citing Articles

Preventive Photobiomodulation for Chemotherapy-Induced Oral Mucositis: A Systematic Review of Randomized Clinical Trials.

Parra-Rojas S, Velazquez-Cayon R, Ciortan-Pop M, Martins M, Cassol Spanemberg J Biomedicines. 2025; 13(2).

PMID: 40002682 PMC: 11852607. DOI: 10.3390/biomedicines13020268.

Light-based therapies and radiodermatitis: a case series report.

Oliveira de Lima T, Freitas K, Batista da Silva K, Rodrigues M, Dos Santos T, Shimozato I EXCLI J. 2024; 23:1276-1286.

PMID: 39624110 PMC: 11610036. DOI: 10.17179/excli2024-7749.

Photobiomodulation in Ophthalmology: A Comprehensive Review of Bench-to-Bedside Research and Clinical Integration.

Garg D, Daigavane S Cureus. 2024; 16(9):e69651.

PMID: 39429338 PMC: 11488463. DOI: 10.7759/cureus.69651.

The supportive use of photobiomodulation on salivary glands: a narrative review and meta-analysis.

Oliveira S, Batista J, Gutierres G, Silva N, Lino-Dos-Santos-Franco A, Rodrigues M Eur Arch Otorhinolaryngol. 2024; 281(6):2793-2805.

PMID: 38189964 DOI: 10.1007/s00405-023-08425-8.

Interventions to improve quality of life in patients with head and neck cancers receiving radiation therapy: a scoping review.

Nayak S, George A, Sharan K, Nayak B, Salins N Support Care Cancer. 2023; 32(1):31.

PMID: 38102525 DOI: 10.1007/s00520-023-08197-1.

References

Antunes H, Herchenhorn D, Small I, Araujo C, Pais Viegas C, Cabral E . Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol. 2013; 109(2):297-302. DOI: 10.1016/j.radonc.2013.08.010. View

Ariyawardana A, Cheng K, Kandwal A, Tilly V, Al-Azri A, Galiti D . Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019; 27(10):3985-3995. DOI: 10.1007/s00520-019-04888-w. View

Arora H, Pai K, Maiya A, Vidyasagar M, Rajeev A . Efficacy of He-Ne Laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105(2):180-6, 186.e1. DOI: 10.1016/j.tripleo.2007.07.043. View

Bensadoun R . Photobiomodulation or low-level laser therapy in the management of cancer therapy-induced mucositis, dermatitis and lymphedema. Curr Opin Oncol. 2018; 30(4):226-232. DOI: 10.1097/CCO.0000000000000452. View

Bjordal J, Bensadoun R, Tuner J, Frigo L, Gjerde K, Lopes-Martins R . A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer. 2011; 19(8):1069-77. DOI: 10.1007/s00520-011-1202-0. View

Bianca Brandao T, Morais-Faria K, Ribeiro A, Rivera C, Salvajoli J, Lopes M . Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses. Support Care Cancer. 2018; 26(7):2417-2423. DOI: 10.1007/s00520-018-4046-z. View

Franco P, Martini S, Di Muzio J, Cavallin C, Arcadipane F, Rampino M . Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Med Oncol. 2017; 34(5):81. DOI: 10.1007/s12032-017-0950-1. View

Gautam A, Fernandes D, Vidyasagar M, Maiya A, Guddattu V . Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial. J Photochem Photobiol B. 2015; 144:51-6. DOI: 10.1016/j.jphotobiol.2015.01.011. View

Genot-Klastersky M, Klastersky J, Awada F, Awada A, Crombez P, Martinez M . The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Support Care Cancer. 2008; 16(12):1381-7. DOI: 10.1007/s00520-008-0439-8. View

10.

Gruber S, Bozsaky E, Roitinger E, Schwarz K, Schmidt M, Dorr W . Early inflammatory changes in radiation-induced oral mucositis : Effect of pentoxifylline in a mouse model. Strahlenther Onkol. 2017; 193(6):499-507. PMC: 5438416. DOI: 10.1007/s00066-017-1119-8. View

11.

Guneri P, Epstein J . Late stage diagnosis of oral cancer: components and possible solutions. Oral Oncol. 2014; 50(12):1131-6. DOI: 10.1016/j.oraloncology.2014.09.005. View

12.

Hamblin M, Nelson S, Strahan J . Photobiomodulation and Cancer: What Is the Truth?. Photomed Laser Surg. 2018; 36(5):241-245. PMC: 5946726. DOI: 10.1089/pho.2017.4401. View

13.

Hodgson B, Margolis D, Salzman D, Eastwood D, Tarima S, Williams L . Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Support Care Cancer. 2011; 20(7):1405-15. DOI: 10.1007/s00520-011-1223-8. View

14.

Kauark-Fontes E, Rodrigues-Oliveira L, Epstein J, Faria K, Araujo A, Alcino Monteiro Gueiros L . Cost-effectiveness of photobiomodulation therapy for the prevention and management of cancer treatment toxicities: a systematic review. Support Care Cancer. 2021; 29(6):2875-2884. DOI: 10.1007/s00520-020-05949-1. View

15.

Legoute F, Bensadoun R, Seegers V, Pointreau Y, Caron D, Lang P . Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial. Radiat Oncol. 2019; 14(1):83. PMC: 6530019. DOI: 10.1186/s13014-019-1292-2. View

16.

Lima A, Antequera R, Peres M, Snitcosky I, Federico M, Villar R . Efficacy of low-level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral mucositis. Braz Dent J. 2011; 21(3):186-92. DOI: 10.1590/s0103-64402010000300002. View

17.

Martins A, Morais M, de Sousa-Neto S, de Jesus A, Nogueira T, Valadares M . Photobiomodulation reduces the impact of radiotherapy on oral health-related quality of life due to mucositis-related symptoms in head and neck cancer patients. Lasers Med Sci. 2020; 36(4):903-912. DOI: 10.1007/s10103-020-03167-z. View

18.

Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View

19.

Sonis S . Oral mucositis. Anticancer Drugs. 2011; 22(7):607-12. DOI: 10.1097/CAD.0b013e3283462086. View

20.

Sonis S . Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity?. Support Care Cancer. 2019; 28(2):423-424. DOI: 10.1007/s00520-019-05146-9. View